Skin and Mucosal Delivery (Focus Group – SMD)
Juhaina M. Abu Ershaid, n/a
Assistant Professor of Pharmaceutical Technology and Drug Delivery
Isra University, Jordan
al-Jami'ah, Jordan
Acne is a highly prevalent skin disorder, affecting more than 85% of individuals worldwide. It is an inflammatory cutaneous condition that impairs patients’ quality of life and is often associated with psychological consequences such as depression, anxiety and social distress. The development of effective and safe acne treatments is essential. Recently, minocycline-loaded microneedles have been explored to enable localized drug delivery while minimizing systemic side effects. However, previously reported fabrication methods are complex, limiting scalability. This study aims to develop minocycline microneedles using a simple, cost-effective, and scalable approach as shown in Figure 1.